Kirby Mcinerney LLP announces investigations against Zynex,

New York, March 14, 2025 (Globe Newswire) – The law firm of Kirby Mcinerney LLP examines potential claims against Zynex, Inc. (“Zynex” or the “company”) (Nasdaq: Zyxi). The investigation concerns whether Zynex and/or certain of his civil servants have violated the federal securities laws and/or other illegal business practices.

[LEARN MORE ABOUT THE INVESTIGATION]

On March 11, 2025, Zynex released its fourth quarter and the full year 2024 financial results after the market lessons and unveiled sales in the quarter in the quarter “due to slower than normal payments”. The company also announced that it was “announced that Tricare temporarily suspended payments when checking previous claims”. Tricare is the health program for uniformed service members and “currently approximately 20 to 25% of [the Company’s] Annual turnover. “In this news, the price for Zynex shares dropped by $ 3.59 per share or about 51%from USD 7.00 per share on March 11, 2025 to $ 3.41 on March 12, 2025.

If you bought Zynex Securities or otherwise have acquired information or would like to learn more about this examination, contact Thomas W. Elrod from Kirby Mcinerney LLP via e -e -Mail at investigations@kmllp.com or by filling out the following form to discuss your rights or interests with regard to these affairs without any costs.

[CONTACT US]

Kirby Mcinerney LLP is a law firm based in New York, which focuses on legal disputes of securities, antitrust rights, whistleblower and consumer disputes. The company's efforts on behalf of the shareholders in securities disputes have led to a total of billions of dollars to retreat areas.

In some jurisdiction, this press release can be regarded as a lawyer's advertising in accordance with the applicable law and ethical rules.

Contacts
Kirby Mcinerney LLP
Thomas W. Elrod, ESQ.
212-699-1180
https://www.kmllp.com
Investions@kmllp.com